211949-57-4

Basic information

• Product Name: 2-Thio-1,3-oxazolo[4,5-b]pyridine
• Synonyms: 2-Thio-1,3-oxazolo[4,5-b]pyridine
• CAS NO: 211949-57-4
• Molecular Formula: C6H4N2OS
• Molecular Weight: 152.17376
• Mol File: 211949-57-4.mol
• Article Data: 19

Chemical Properties

• Boiling Point: 284.1°C at 760 mmHg
• Flash Point: 125.6°C
• Appearance: /
• Density: 1.53g/cm³
• Vapor Pressure: 0.00303mmHg at 25°C
• Refractive Index: 1.729
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 2.91±0.50(Predicted)
• CAS DataBase Reference: 2-Thio-1,3-oxazolo[4,5-b]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Thio-1,3-oxazolo[4,5-b]pyridine(211949-57-4)
• EPA Substance Registry System: 2-Thio-1,3-oxazolo[4,5-b]pyridine(211949-57-4)

Safety Data

• Hazardous Substances Data: 211949-57-4(Hazardous Substances Data)

Usage

General Description

2-Thio-1,3-oxazolo[4,5-b]pyridine is a chemical compound with the molecular formula C6H5NOS. It is a heterocyclic compound containing both sulfur and nitrogen atoms in its structure. 2-Thio-1,3-oxazolo[4,5-b]pyridine has potential pharmacological properties and has been studied for its potential use in pharmaceutical applications. It is also used as a building block in organic synthesis for the preparation of various other compounds. Due to its unique structure and properties, 2-Thio-1,3-oxazolo[4,5-b]pyridine is of interest to researchers in the fields of medicinal chemistry and chemical synthesis.

InChI:InChI=1/C6H4N2OS/c10-6-8-5-4(9-6)2-1-3-7-5/h1-3H,(H,7,8,10)

Upstream product

• 16867-03-1 2-amino-3-hydroxypyridine 
• 137-26-8 Thiram 
• 75-15-0 carbon disulfide 
• 140-89-6 potassium ethyl xanthogenate 

Downstream Products

• 300672-80-4 2-(3H-oxazolo[4,5-b]pyridin-2-ylideneamino)-ethanethiol 
• 113520-22-2 1-(oxazolo[4,5-b]pyridin-2-yl)piperazine 
• 325976-45-2 2-chlorooxazolo[4,5-b]pyridine 
• 169205-95-2 2-(methylthio)oxazolo[4,5-b]pyridine 
• 931321-16-3 2-morpholino-6-nitrooxazolo[4,5-b]pyridine 

Relevant articles and documents

Discovery of CA-4948, an Orally Bioavailable IRAK4 Inhibitor for Treatment of Hematologic Malignancies

Small molecule potent IRAK4 inhibitors from a novel bicyclic heterocycle class were designed and synthesized based on hits identified from Aurigene's compound library. The advanced lead compound, CA-4948, demonstrated good cellular activity in ABC DLBCL and AML cell lines. Inhibition of TLR signaling leading to decreased IL-6 levels was also observed in whole blood assays. CA-4948 demonstrated moderate to high selectivity in a panel of 329 kinases as well as exhibited desirable ADME and PK profiles including good oral bioavailability in mice, rat, and dog and showed >90% tumor growth inhibition in relevant tumor models with excellent correlation with in vivo PD modulation. CA-4948 was well tolerated in toxicity studies in both mouse and dog at efficacious exposure. The overall profile of CA-4948 prompted us to select it as a clinical candidate for evaluation in patients with relapsed or refractory hematologic malignancies including non-Hodgkin lymphoma and acute myeloid leukemia.

Compounds for Pain Treatment, Compositions Comprising Same, and Methods of Using Same

The invention relates to compounds of formula (I), compositions containing the same, and methods for treating and/or diminishing pain in a subject in need thereof. The compounds of formula (I) are effective for treating opioid-induced tachyphylaxis and op

An environmentally benign and efficient synthesis of substituted benzothiazole-2-thiols, benzoxazole-2-thiols, and benzimidazoline-2-thiones in water

An efficient and practical method for the one-step synthesis of benzothiazole-2-thiols, benzoxazole-2-thiols and benzimidazoline-2-thiones by cyclization of 2-aminothiophenols, 2-aminophenols, and 1,2-phenylenediamines with tetramethylthiuram disulfide (TMTD) in water was described. The features of this method include metal/ligand-free, excellent yield, short reaction time and broad substrate scope. The method provides a facile and convenient preparation of some potentially biologically active compounds.